Drw Securities, LLC Immuno Gen, Inc. Transaction History

Drw Securities, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$9.52 - $12.15 $180,880 - $230,850	-19,000 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$6.7 - $12.95 $33,500 - $64,750	-5,000 Reduced 20.83%	19,000 $200,000
Q4 2017 Feb 14, 2018	BUY	$5.07 - $7.92 $121,680 - $190,080	24,000	24,000 $154,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Drw Securities, LLC with notifications on news.